Abstract
Gene therapy presents a transformative strategy for the treatment of genetic disorders, cancer, and infectious diseases. However, the safe and efficient delivery of genetic material remains a significant challenge. Pharmaceutical nanocarriers have emerged as a powerful tool for overcoming biological barriers and enabling targeted, controlled gene delivery. This article discusses the types of nanocarriers used for gene delivery—including liposomes, dendrimers, polymeric nanoparticles, and lipid-polymer hybrids—their physicochemical properties, delivery mechanisms, and potential clinical applications. Emphasis is placed on recent innovations that enhance transfection efficiency while minimizing cytotoxicity. Challenges, regulatory considerations, and future prospects in gene therapy are also addressed.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Sarah Hameed (Author)